Literature DB >> 1976032

Studies of the HER-2/neu proto-oncogene in human breast cancer.

D J Slamon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1976032     DOI： 10.3109/07357909009017573

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  21 in total

1.  Inhibition of phosphoinositide 3-kinase enhances the cytotoxicity of AG1478, an epidermal growth factor receptor inhibitor, in breast cancer cells.

Authors:  Ping Li; Artour Torossian; Qing Zhang; Wen-Cai Xu; Shen Fu
Journal:  Med Oncol       Date:  2012-06-23       Impact factor: 3.064

2.  Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry.

Authors:  James O Ebot Enaw; Alicia K Smith
Journal:  J Neurol Psychol       Date:  2013-11-01

3.  Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology.

Authors:  Hyun Ae Jung; Yeon Hee Park; Moonjin Kim; Sungmin Kim; Won Jin Chang; Moon Ki Choi; Jung Yong Hong; Seok Won Kim; Won Ho Kil; Jeong Eon Lee; Seok Jin Nam; Jin Seok Ahn; Young-Hyuck Im
Journal:  Tumour Biol       Date:  2014-10-19

4.  Hunk is required for HER2/neu-induced mammary tumorigenesis.

Authors:  Elizabeth S Yeh; Thomas W Yang; Jason J Jung; Heather P Gardner; Robert D Cardiff; Lewis A Chodosh
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

5.  HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Authors:  Nadire Duru; Ming Fan; Demet Candas; Cheikh Menaa; Hsin-Chen Liu; Danupon Nantajit; Yunfei Wen; Kai Xiao; Angela Eldridge; Brett A Chromy; Shiyong Li; Douglas R Spitz; Kit S Lam; Max S Wicha; Jian Jian Li
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

6.  Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.

Authors:  Vitor Sousa; Diana Reis; Maria Silva; Ana Maria Alarcão; Ana Filipa Ladeirinha; Maria João d'Aguiar; Teresa Ferreira; Sandra Caramujo-Balseiro; Lina Carvalho
Journal:  Virchows Arch       Date:  2016-05-19       Impact factor: 4.064

7.  Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification.

Authors:  Michaela Aubele; Sanja Vidojkovic; Herbert Braselmann; Dominique Ritterswürden; Gert Auer; Mike J Atkinson; Soile Tapio; Heinz Höfler; Sandra Rauser; John M S Bartlett
Journal:  Virchows Arch       Date:  2009-07-21       Impact factor: 4.064

8.  MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT.

Authors:  Andrew J Giustini; Alicia A Petryk; Shiraz M Cassim; Jennifer A Tate; Ian Baker; P Jack Hoopes
Journal:  Nano Life       Date:  2010-03

9.  Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.

Authors:  Pieter J A Eichhorn; Magüi Gili; Maurizio Scaltriti; Violeta Serra; Marta Guzman; Wouter Nijkamp; Roderick L Beijersbergen; Vanesa Valero; Joan Seoane; René Bernards; José Baselga
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

Review 10.  Fundamentals to Apply Magnetic Nanoparticles for Hyperthermia Therapy.

Authors:  Hira Fatima; Tawatchai Charinpanitkul; Kyo-Seon Kim
Journal:  Nanomaterials (Basel)       Date:  2021-05-01       Impact factor: 5.076
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.